620600-61-5 Usage
Uses
Used in Silicone Material and Polymer Production:
(4-(2-BROMOETHYL)PHENOXY)-(1,1-DIMETHYLETHYL)DIMETHYLSILANE is utilized as a key component in the manufacturing process of silicone materials and polymers, contributing to their enhanced properties and performance.
Used in Organic Compound Synthesis:
(4-(2-BROMOETHYL)PHENOXY)-(1,1-DIMETHYLETHYL)DIMETHYLSILANE serves as an intermediate or reactant in the synthesis of various organic compounds, enabling the creation of a wide range of chemical products.
Used in Surface Modification and Protection:
(4-(2-BROMOETHYL)PHENOXY)-(1,1-DIMETHYLETHYL)DIMETHYLSILANE is employed as a surface modifier and protector, enhancing the durability and functionality of treated surfaces across different industries.
Used in Coating, Adhesive, and Sealant Development:
(4-(2-BROMOETHYL)PHENOXY)-(1,1-DIMETHYLETHYL)DIMETHYLSILANE is leveraged in the development of specialized coatings, adhesives, and sealants, where its reactivity and structural properties contribute to improved product performance and versatility.
Check Digit Verification of cas no
The CAS Registry Mumber 620600-61-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,0,6,0 and 0 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 620600-61:
(8*6)+(7*2)+(6*0)+(5*6)+(4*0)+(3*0)+(2*6)+(1*1)=105
105 % 10 = 5
So 620600-61-5 is a valid CAS Registry Number.
620600-61-5Relevant academic research and scientific papers
NITROGEN-CONTAINING HETEROCYCLYL KETONES AND METHODS OF USE
-
Page/Page column 148-149, (2008/12/08)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Compounds for myocardial perfusion imaging
-
Page/Page column 11, (2010/10/20)
The present disclosure is directed to compounds comprising imaging moieties and their use for diagnosing certain disorders.
PHENETHANOLAMINE DERIVATIVES
-
Page/Page column 61, (2010/02/07)
The present invention relates to novel compounds of formula (I), or a salt, solvate, or physiologically functional derivative thereof, to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
